Aspirin intolerance.
Morassut
P
P
Department of Medicine, University of Ottawa, Ontario, Canada.
Yang
W
W
Karsh
J
J
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000494:pharmacology; D001241:Aspirin / Q000009:adverse effects* / Q000494:pharmacology; D001696:Biomechanical Phenomena; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D003429:Cross Reactions; D016861:Cyclooxygenase Inhibitors; D003888:Desensitization, Immunologic; D004342:Drug Hypersensitivity; D006801:Humans; D007159:Immunologic Tests; D008407:Mast Cells / Q000378:metabolism; D008954:Models, Biological; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D011453:Prostaglandins / Q000378:metabolism; D012307:Risk Factors; D013645:Tartrazine / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D011453:Prostaglandins; D011451:Prostaglandin-Endoperoxide Synthases; D013645:Tartrazine; D001241:Aspirin